Argenx Appoints Karen Massey CEO, Tim Van Hauwermeiren Board Chairperson
argenx SE (Euronext & Nasdaq: ARGX), a global immunology innovator committed to improving the lives of people suffering from severe autoimmune diseases, today announced the results of the Annual General Meeting of


























